Results 121 to 130 of about 7,115 (194)

Olmesartan-associated enteropathy presenting with metabolic acidosis and acute kidney injury requiring hemodialysis: a rechallenge-confirmed case. [PDF]

CEN Case Rep
Sugiura T, Ito S, Ozeki T, Yokoe Y, Tsunoda Y, Kato M, Yasuda K, Maruyama S.   +7 more
europepmc   +1 more source

Reversal of left ventricular hypertrophy with sacubitril/valsartan vs. standard antihypertensive agents in hypertension: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Tang W, Qin W, Su Y, Yang F, He G.
europepmc   +1 more source

Olmesartan-related sprue-like enteropathy presenting as severe diarrhoea. [PDF]

BMJ Case Rep
Suardi S, Vicardi M, Spillere C, Leidi P, Pecori S, Campagnola P, Friso S, Martinelli N.   +7 more
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights. [PDF]

Kidney360
Miyata KN, Miner JH.
europepmc   +1 more source

Trough-to-peak ratios and elimination half-lives of antihypertensive drugs: implications for 24-hour blood pressure control in primary care. [PDF]

Aten Primaria
Serrat-Costa M, Coll de Tuero G, Vinyoles Bargalló E, Estévez Rovira E, Rosinach Bonet J, Albaladejo Blanco C, Agudo Ugena JP, Paz Bermejo M, Torras Borrell J, Rebagliato Nadal O, Vallès-Callol JA, Ricart W.   +11 more
europepmc   +1 more source

Case Report: Olmesartan-Induced Enteropathy Mimicking Amyloidosis in the Setting of New Multiple Myeloma Diagnosis. [PDF]

Case Rep Gastroenterol
Osman MM, Salgado-de la Mora M, Sharma R, Ahmed A, Fansa S, Massad T, Kawas H, El Hag M, Rotenberg V.   +8 more
europepmc   +1 more source

Zilebesiran, a Small Interfering RNA Therapeutic Targeting Angiotensinogen: Mechanism, Clinical Evidence, Safety, and Implementation Considerations. [PDF]

Life (Basel)
Jawaria, Noor A, Zarlashat Y, Khan MEA, Loureiro EM, Dósa E.   +5 more
europepmc   +1 more source

An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity. [PDF]

Molecules
Gómez-Escobedo R, Méndez-Álvarez D, Paz-González AD, Ortiz-Pérez E, Vázquez-Jiménez LK, Martínez-Vázquez AV, Delgado-Maldonado T, Quintero-Solano JM, Vázquez C, Saavedra E, Avalos-Navarro G, Vázquez K, Rivera G, Nogueda-Torres B.   +13 more
europepmc   +1 more source

Losartan-Induced Sprue-Like Enteropathy Presenting With Isolated Ileal Villous Atrophy: A Report of a Rare and Atypical Case. [PDF]

Cureus
Berrocal C, Vasquez Villada J, Galindo Orrego P, Libreros Mejia I, Delgadillo Arco DM, Suguimoto Erasso AM, Caballero Lagares M, Solano Álvarez SE, Carrascal López VA.   +8 more
europepmc   +1 more source

Drug-induced psoriasis following sacubitril/valsartan: a case report and literature review. [PDF]

BMC Cardiovasc Disord
Tang T, Guo M, Yu H, Zhang Y, Lei S, Li S, Chen W, Lou Y.   +7 more
europepmc   +1 more source